Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause: A Prospective Double-blind Randomized Trial
The goal of this interventional study is to compare the efficacy and safety of vaginal hyaluronic acid, arginine and liposome gel versus vaginal lubricant in the treatment of genitourinary syndrome of menopause in postmenopausal women. The main question it aims to answer is:
Is vaginal hyaluronic acid, arginine and liposome gel more effective than vaginal lubricant in the treatment of genitourinary syndrome of menopause in postmenopausal women
Participants will be randomized into 2 treatment groups: vaginal hyaluronic acid, arginine and liposome group and vaginal lubricant group.
Researchers will compare whether vaginal hyaluronic acid, arginine and liposome group has better improvement than vaginal lubricant group.
A Phase II, Randomised Controlled Trial to Evaluate the Efficacy and Safety of Moisturising Creams With or Without Palm-oil-derived Vitamin E Concentrate in Addition to Urea-based Cream or Urea-based Cream Alone in Capecitabine-associated Palmar-Plantar Erythrodysesthesia (ECaPPE)
This is a single-centre, phase II, three-arm, randomised controlled trial to evaluate the efficacy and safety of a cosmetic moisturising cream containing palm-oil-derived vitamin E concentrate or a similar moisturising cream without the vitamin E concentrate in addition to urea-based cream, or urea-based cream alone (1:1:1) in patients who are receiving capecitabine-based cancer therapy and develop capecitabine-associated PPE of NCI-CTCAE grade 1.
A Prospective Observational Study on the Role of Transthoracic Ultrasound in Differentiating Tuberculous From Malignant Pleural Effusion
Primary Endpoint
To assess the prevalence and diagnostic performance of pre-determined echographic features in predicting the diagnosis of TBE from MPE.
To determine the clinical, pleural fluid and echographic parameters that were different among TBE and MPE and to establish a clinical prediction model for TBE.
Secondary Endpoint
To assess the correlation between pleural fluid parameters with ultrasound and medical thoracoscopic finding.
To assess the optimal Pf ADA cut-off value to differentiate TBE from MPE in our region.
100 项与 Sarawak General Hospital 相关的临床结果
0 项与 Sarawak General Hospital 相关的专利(医药)
2022-08-31·Annals of the Rheumatic Diseases
Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic
作者: Chuah, Seow Lin ; Teh, Cheng Lay ; Akbar, Sharifah Aishah Wan Mohd ; Cheong, Yaw Kiet ; Singh, Benjamin Sachdev Manjit
2022-08-31·Annals of the Rheumatic Diseases
Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia
作者: Wan, Sharifah Aishah ; Teh, Cheng Lay ; Singh, Benjamin Sachdev Manjit ; Cheong, Yaw Kiet ; Chuah, Seow Lin ; Jobli, Ahmad Tirmizi
2021-05-31·Annals of the Rheumatic Diseases
COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine
作者: Teh, Cheng Lay ; Cheong, Yaw Kiet ; Wan Musa, Wan Rosmaiza ; Wan Mohd Akbar, Sharifah Aishah ; Husin, Noraini Mat ; Gun, Suk Chyn
The authors share the clin. course of COVID-19 among patients with SLE in Malaysia. The most common presentations were fever and cough. Most patients have lymphopenia. All the patients had pneumonia in the chest X-rays. COVID-19 among our patients with SLE on hydroxychloroquine has a severe disease course needing aggressive therapy. Background hydroxychloroquine treatment for SLE did not prevent COVID-19 among our patients.
100 项与 Sarawak General Hospital 相关的药物交易
100 项与 Sarawak General Hospital 相关的转化医学